Urologix, Inc. (ULGX)

Urologix Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Fiscal Year	Current	FY 2014	FY 2013	FY 2012	FY 2011	FY 2010
Period Ending	Jan 13, 2025	Jun 30, 2014	Jun 30, 2013	Jun 30, 2012	Jun 30, 2011	Jun 30, 2010
Market Capitalization	0	4	4	15	14	16
Market Cap Growth	-50.17%	4.29%	-77.19%	11.19%	-10.86%	-13.42%
Enterprise Value	6	8	-2	14	10	10
Last Close Price	0.00	0.17	0.17	0.77	0.95	1.07
PS Ratio	0.00	0.26	0.21	0.90	1.10	1.05
PB Ratio	-0.20	-0.53	8.37	24.60	2.86	1.89
P/TBV Ratio	-	-	-	-	2.92	1.92
EV/Sales Ratio	0.54	0.58	-	0.80	0.80	0.66
Debt / Equity Ratio	-0.66	-0.76	12.70	-	-	-
Asset Turnover	1.67	1.54	1.31	1.75	1.48	1.32
Inventory Turnover	4.81	5.47	5.39	6.71	4.59	4.52
Quick Ratio	0.31	0.52	1.68	0.55	2.52	3.55
Current Ratio	0.56	0.86	2.32	0.79	3.30	4.37
Return on Equity (ROE)	-	-	-820.65%	-171.60%	-57.20%	-23.93%
Return on Assets (ROA)	-7.62%	-27.30%	-21.11%	-24.87%	-26.69%	-12.63%
Return on Capital (ROIC)	-	-120.86%	-83.40%	-88.36%	-34.70%	-15.56%
Earnings Yield	-219360.90%	-207.61%	-122.15%	-30.48%	-26.95%	-13.96%
FCF Yield	-12922.93%	-42.62%	-58.00%	-5.00%	-19.07%	-8.60%
Buyback Yield / Dilution	-2.26%	-2.49%	-40.45%	-1.27%	-0.33%	-0.27%
Total Shareholder Return	-2.26%	-2.49%	-40.45%	-1.27%	-0.33%	-0.27%

Source: S&P Capital IQ. Standard template. Financial Sources.